Research on AD treatment has been evolving in a variety of ways, such as anti-etiological immunotherapy, gene therapy, anti-inflammatory therapy, anti-amyloid and anti-tau treatment strategies, symptomatic treatments such as glutamatergic, cholinergic-based therapy, and combining cutting-edge areas of artificial intelligence. This evidence concerns the gene MAPT and Alzheimer disease.